Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Income from Continuing Operations (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Income from Continuing Operations for 16 consecutive years, with 1308000.0 as the latest value for Q3 2025.

  • Quarterly Income from Continuing Operations rose 126.04% to 1308000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1751000.0 through Sep 2025, up 108.98% year-over-year, with the annual reading at 16449000.0 for FY2024, 1225.46% down from the prior year.
  • Income from Continuing Operations for Q3 2025 was 1308000.0 at Xtant Medical Holdings, down from 3550000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 9231000.0 in Q3 2023, with the low at 6204000.0 in Q4 2023.
  • Average Income from Continuing Operations over 5 years is 1379105.26, with a median of 2190000.0 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations plummeted 7531.03% in 2022, then skyrocketed 492.31% in 2023.
  • Over 5 years, Income from Continuing Operations stood at 2377000.0 in 2021, then grew by 7.07% to 2209000.0 in 2022, then tumbled by 180.85% to 6204000.0 in 2023, then skyrocketed by 48.98% to 3165000.0 in 2024, then surged by 141.33% to 1308000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 1308000.0, 3550000.0, and 58000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.